Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A
Supharat Jariyakosol,1,2 Lita Uthaithammarat,1,2 Nattakarn Chatwichaikul,1,2 Ngamjit Kasetsuwan,1– 3 Yuda Chongpison4 1Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 2Ophthalmology Department, King Chulalongkorn Memorial Hospital, Thai Red Cr...
Guardado en:
Autores principales: | Jariyakosol S, Uthaithammarat L, Chatwichaikul N, Kasetsuwan N, Chongpison Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c904971fa3b4447488e4a92722ab4dbc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
por: Dong H, et al.
Publicado: (2018) -
Evaluation of Intraocular Pressure After Water Drinking Test in Patients with Unilateral Hemifacial Spasm
por: Low JR, et al.
Publicado: (2020) -
Making the diagnosis of Sjögren’s syndrome in patients with dry eye
por: Beckman KA, et al.
Publicado: (2015) -
Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
por: Yeu E, et al.
Publicado: (2020) -
Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
por: Silverstein S, et al.
Publicado: (2020)